NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Appili Therapeutics Inc (OTCQX: APLIF)

 
APLIF Technical Analysis
1
As on 19th Jul 2024 APLIF STOCK Price closed @ 0.03 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

APLIFSTOCK Price

Open 0.03 Change Price %
High 0.03 1 Day N/A N/A
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 6000 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
OTCQX USA Most Active Stocks
NCPL 0.10 %
GBTC 59.68 %
ETHE 29.71 %
RHHBY 39.27 %
ZNOG 0.06 %
LOMLF 0.25 %
EMHTF 0.04 33.33%
AOTVF 0.31 %
TRSSF 2.19 -0.90%
ITMSF 0.45 %
 
OTCQX USA Top Gainers Stocks
VVCIF 0.02 100.00%
EMHTF 0.04 33.33%
UNRV 0.85 23.19%
DECPF 12.97 11.81%
HNCKF 0.21 10.53%
HNCKF 0.21 10.53%
LONE 16.00 6.24%
FTSSF 0.24 4.35%
CRTPF 3.41 4.28%
GRFXY 1.23 4.24%
 
OTCQX USA Top Losers Stocks
AKOWF 0.05 -76.19%
ZNOGW 1.05 -19.23%
IDAID 4.11 -11.61%
VQS 2.73 -11.11%
VQS 2.73 -11.11%
VQS 2.73 -11.11%
MTENY 0.28 -9.68%
TGODF 0.22 -8.33%
WDDMF 0.12 -7.69%
WPTIF 20.10 -7.59%
 
 
APLIF
Daily Charts
APLIF
Intraday Charts
Whats New @
Bazaartrend
APLIF
Free Analysis
 
APLIF Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
APLIF Forecast July 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
APLIF Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
APLIF Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
APLIF Other Details
Segment EQ
Market Capital 44826376.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
APLIF Address
APLIF
 
APLIF Latest News
 
Your Comments and Response on Appili Therapeutics Inc
 
APLIF Business Profile
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada. Address: #21-1344 Summer Street, Halifax, NS, Canada, B3H 0A8
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service